Interventional pulmonology is a relatively new field in pulmonary medicine. Interventional pulmonology uses endoscopy and other tools to diagnose and treat conditions in the lungs and chest.
The global Interventional Lung Disease market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Interventional Lung Disease is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Interventional Lung Disease is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Interventional Lung Disease is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Interventional Lung Disease include Boston Scientific, Olympus, FUJIFILM, Becton, Dickinson and Company, Smiths Group, Cook Medical, Vygon, PENTAX Medical and Clarus Medical, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Interventional Lung Disease, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Interventional Lung Disease, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Interventional Lung Disease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Interventional Lung Disease sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Interventional Lung Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Interventional Lung Disease sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
FUJIFILM
Becton, Dickinson and Company
Smiths Group
Cook Medical
Vygon
PENTAX Medical
Clarus Medical
HUGER Medical Instrument
Richard Wolf
Karl Storz
Taewoong Medical
ELLA - CS
Segment by Type
Bronchoscopes
Respiratory Endotherapy Devices
ENB Systems
Pleuroscopes
Other
Segment by Application
Hospital
Emergency Center
Clinic
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Interventional Lung Disease in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Interventional Lung Disease manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Interventional Lung Disease sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Interventional Lung Disease Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Interventional Lung Disease 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Bronchoscopes
1.2.3 Respiratory Endotherapy Devices
1.2.4 ENB Systems
1.2.5 Pleuroscopes
1.2.6 Other
1.3 麻豆原创 by Application
1.3.1 Global Interventional Lung Disease 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Emergency Center
1.3.4 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Interventional Lung Disease Sales Estimates and Forecasts 2019-2030
2.2 Global Interventional Lung Disease Revenue by Region
2.2.1 Global Interventional Lung Disease Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Interventional Lung Disease Revenue by Region (2019-2024)
2.2.3 Global Interventional Lung Disease Revenue by Region (2025-2030)
2.2.4 Global Interventional Lung Disease Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Interventional Lung Disease Sales Estimates and Forecasts 2019-2030
2.4 Global Interventional Lung Disease Sales by Region
2.4.1 Global Interventional Lung Disease Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Interventional Lung Disease Sales by Region (2019-2024)
2.4.3 Global Interventional Lung Disease Sales by Region (2025-2030)
2.4.4 Global Interventional Lung Disease Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Interventional Lung Disease Sales by Manufacturers
3.1.1 Global Interventional Lung Disease Sales by Manufacturers (2019-2024)
3.1.2 Global Interventional Lung Disease Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Interventional Lung Disease in 2023
3.2 Global Interventional Lung Disease Revenue by Manufacturers
3.2.1 Global Interventional Lung Disease Revenue by Manufacturers (2019-2024)
3.2.2 Global Interventional Lung Disease Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Interventional Lung Disease Revenue in 2023
3.3 Global Key Players of Interventional Lung Disease, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Interventional Lung Disease Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Interventional Lung Disease 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Interventional Lung Disease, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Interventional Lung Disease, Product Offered and Application
3.8 Global Key Manufacturers of Interventional Lung Disease, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Interventional Lung Disease Sales by Type
4.1.1 Global Interventional Lung Disease Historical Sales by Type (2019-2024)
4.1.2 Global Interventional Lung Disease Forecasted Sales by Type (2025-2030)
4.1.3 Global Interventional Lung Disease Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Interventional Lung Disease Revenue by Type
4.2.1 Global Interventional Lung Disease Historical Revenue by Type (2019-2024)
4.2.2 Global Interventional Lung Disease Forecasted Revenue by Type (2025-2030)
4.2.3 Global Interventional Lung Disease Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Interventional Lung Disease Price by Type
4.3.1 Global Interventional Lung Disease Price by Type (2019-2024)
4.3.2 Global Interventional Lung Disease Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Interventional Lung Disease Sales by Application
5.1.1 Global Interventional Lung Disease Historical Sales by Application (2019-2024)
5.1.2 Global Interventional Lung Disease Forecasted Sales by Application (2025-2030)
5.1.3 Global Interventional Lung Disease Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Interventional Lung Disease Revenue by Application
5.2.1 Global Interventional Lung Disease Historical Revenue by Application (2019-2024)
5.2.2 Global Interventional Lung Disease Forecasted Revenue by Application (2025-2030)
5.2.3 Global Interventional Lung Disease Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Interventional Lung Disease Price by Application
5.3.1 Global Interventional Lung Disease Price by Application (2019-2024)
5.3.2 Global Interventional Lung Disease Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Interventional Lung Disease 麻豆原创 Size by Type
6.1.1 US & Canada Interventional Lung Disease Sales by Type (2019-2030)
6.1.2 US & Canada Interventional Lung Disease Revenue by Type (2019-2030)
6.2 US & Canada Interventional Lung Disease 麻豆原创 Size by Application
6.2.1 US & Canada Interventional Lung Disease Sales by Application (2019-2030)
6.2.2 US & Canada Interventional Lung Disease Revenue by Application (2019-2030)
6.3 US & Canada Interventional Lung Disease 麻豆原创 Size by Country
6.3.1 US & Canada Interventional Lung Disease Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Interventional Lung Disease Sales by Country (2019-2030)
6.3.3 US & Canada Interventional Lung Disease Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Interventional Lung Disease 麻豆原创 Size by Type
7.1.1 Europe Interventional Lung Disease Sales by Type (2019-2030)
7.1.2 Europe Interventional Lung Disease Revenue by Type (2019-2030)
7.2 Europe Interventional Lung Disease 麻豆原创 Size by Application
7.2.1 Europe Interventional Lung Disease Sales by Application (2019-2030)
7.2.2 Europe Interventional Lung Disease Revenue by Application (2019-2030)
7.3 Europe Interventional Lung Disease 麻豆原创 Size by Country
7.3.1 Europe Interventional Lung Disease Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Interventional Lung Disease Sales by Country (2019-2030)
7.3.3 Europe Interventional Lung Disease Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Interventional Lung Disease 麻豆原创 Size
8.1.1 China Interventional Lung Disease Sales (2019-2030)
8.1.2 China Interventional Lung Disease Revenue (2019-2030)
8.2 China Interventional Lung Disease 麻豆原创 Size by Application
8.2.1 China Interventional Lung Disease Sales by Application (2019-2030)
8.2.2 China Interventional Lung Disease Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Interventional Lung Disease 麻豆原创 Size by Type
9.1.1 Asia Interventional Lung Disease Sales by Type (2019-2030)
9.1.2 Asia Interventional Lung Disease Revenue by Type (2019-2030)
9.2 Asia Interventional Lung Disease 麻豆原创 Size by Application
9.2.1 Asia Interventional Lung Disease Sales by Application (2019-2030)
9.2.2 Asia Interventional Lung Disease Revenue by Application (2019-2030)
9.3 Asia Interventional Lung Disease Sales by Region
9.3.1 Asia Interventional Lung Disease Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Interventional Lung Disease Revenue by Region (2019-2030)
9.3.3 Asia Interventional Lung Disease Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Interventional Lung Disease 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Interventional Lung Disease Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Interventional Lung Disease Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Interventional Lung Disease 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Interventional Lung Disease Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Interventional Lung Disease Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Interventional Lung Disease Sales by Country
10.3.1 Middle East, Africa and Latin America Interventional Lung Disease Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Interventional Lung Disease Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Interventional Lung Disease Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Information
11.1.2 Boston Scientific Overview
11.1.3 Boston Scientific Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Boston Scientific Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boston Scientific Recent Developments
11.2 Olympus
11.2.1 Olympus Company Information
11.2.2 Olympus Overview
11.2.3 Olympus Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Olympus Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Olympus Recent Developments
11.3 FUJIFILM
11.3.1 FUJIFILM Company Information
11.3.2 FUJIFILM Overview
11.3.3 FUJIFILM Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 FUJIFILM Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 FUJIFILM Recent Developments
11.4 Becton, Dickinson and Company
11.4.1 Becton, Dickinson and Company Company Information
11.4.2 Becton, Dickinson and Company Overview
11.4.3 Becton, Dickinson and Company Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Becton, Dickinson and Company Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Becton, Dickinson and Company Recent Developments
11.5 Smiths Group
11.5.1 Smiths Group Company Information
11.5.2 Smiths Group Overview
11.5.3 Smiths Group Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Smiths Group Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Smiths Group Recent Developments
11.6 Cook Medical
11.6.1 Cook Medical Company Information
11.6.2 Cook Medical Overview
11.6.3 Cook Medical Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Cook Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cook Medical Recent Developments
11.7 Vygon
11.7.1 Vygon Company Information
11.7.2 Vygon Overview
11.7.3 Vygon Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Vygon Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Vygon Recent Developments
11.8 PENTAX Medical
11.8.1 PENTAX Medical Company Information
11.8.2 PENTAX Medical Overview
11.8.3 PENTAX Medical Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 PENTAX Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 PENTAX Medical Recent Developments
11.9 Clarus Medical
11.9.1 Clarus Medical Company Information
11.9.2 Clarus Medical Overview
11.9.3 Clarus Medical Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Clarus Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Clarus Medical Recent Developments
11.10 HUGER Medical Instrument
11.10.1 HUGER Medical Instrument Company Information
11.10.2 HUGER Medical Instrument Overview
11.10.3 HUGER Medical Instrument Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 HUGER Medical Instrument Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 HUGER Medical Instrument Recent Developments
11.11 Richard Wolf
11.11.1 Richard Wolf Company Information
11.11.2 Richard Wolf Overview
11.11.3 Richard Wolf Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Richard Wolf Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Richard Wolf Recent Developments
11.12 Karl Storz
11.12.1 Karl Storz Company Information
11.12.2 Karl Storz Overview
11.12.3 Karl Storz Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Karl Storz Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Karl Storz Recent Developments
11.13 Taewoong Medical
11.13.1 Taewoong Medical Company Information
11.13.2 Taewoong Medical Overview
11.13.3 Taewoong Medical Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Taewoong Medical Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Taewoong Medical Recent Developments
11.14 ELLA - CS
11.14.1 ELLA - CS Company Information
11.14.2 ELLA - CS Overview
11.14.3 ELLA - CS Interventional Lung Disease Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 ELLA - CS Interventional Lung Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 ELLA - CS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Interventional Lung Disease Industry Chain Analysis
12.2 Interventional Lung Disease Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Interventional Lung Disease Production Mode & Process
12.4 Interventional Lung Disease Sales and 麻豆原创ing
12.4.1 Interventional Lung Disease Sales Channels
12.4.2 Interventional Lung Disease Distributors
12.5 Interventional Lung Disease Customers
13 麻豆原创 Dynamics
13.1 Interventional Lung Disease Industry Trends
13.2 Interventional Lung Disease 麻豆原创 Drivers
13.3 Interventional Lung Disease 麻豆原创 Challenges
13.4 Interventional Lung Disease 麻豆原创 Restraints
14 Key Findings in The Global Interventional Lung Disease Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Boston Scientific
Olympus
FUJIFILM
Becton, Dickinson and Company
Smiths Group
Cook Medical
Vygon
PENTAX Medical
Clarus Medical
HUGER Medical Instrument
Richard Wolf
Karl Storz
Taewoong Medical
ELLA - CS
听
听
*If Applicable.